Image

Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation

Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation

Recruiting
50-70 years
All
Phase 1
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The goal of this clinical trial is to investigate upper-extremity vibrotactile stimulation with wearables in stroke patients. The main questions it aims to answer are:

Are the wearables well-tolerated by patients? Does the vibrotactile stimulation help regain arm function?

Participants will wear vibrotactile stimulation gloves and shirts for 5 hours daily during their stay at the rehabilitation unit, in addition to conventional therapy. Researchers will compare the treatment group (vibrotactile stimulation wearables) with a control group (conventional therapy only) to see the effects of the vibrotactile stimulation.

Eligibility

Inclusion Criteria:

  • Inpatients at rehabilitation units
  • Unilateral left or right sided ischemic stroke within the previous 2 weeks
  • Have Upper-Extremity Fugl-Meyer scores between 6 and 58
  • Have at least 20 degrees of active shoulder elevation and elbow flexion
  • Expected to stay 1-3 weeks in the rehabilitation unit

Exclusion Criteria:

  • Under anti-spasticity therapy
  • Patients that are dependent on pacemakers
  • Patients that have defibrillators
  • Have lymphedema or AV fistula for dialysis on an arm

Study details
    Stroke

NCT06244719

University of Colorado, Denver

12 April 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.